VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Amneal Pharmaceuticals, Inc. (AMRX) Total Return Calculator with Dividends Reinvested

Amneal Pharmaceuticals, Inc.

Popular:

The total return for Amneal Pharmaceuticals, Inc. (AMRX) stock is +89.69% over the past 12 months. So far it's up 7.58% this year. The 5-year total return is +135.64%, meaning $10,000 invested in AMRX stock 5 years ago would be worth $23,564 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in AMRX 1 year ago, it would be worth $18,864 today — you'd have gained $8,864.

With Dividends Reinvested$18,864+88.64%

Price Only (No DRIP)$18,864+88.64%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in AMRX

1Y$18,969+$8,969 (+89.7%)89.7% CAGR

3Y$67,426+$57,426 (+574.3%)88.9% CAGR

5Y$23,564+$13,564 (+135.6%)18.7% CAGR

10Y$4,570-$5,430 (-54.3%)-7.5% CAGR

15Y$4,971-$5,029 (-50.3%)-4.6% CAGR

20Y$28,673+$18,673 (+186.7%)5.4% CAGR

30Y$28,674+$18,674 (+186.7%)3.6% CAGR

Amneal Pharmaceuticals, Inc. did not pay dividends during this period. Total return = price return.

Loading AMRX total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+7.58%	—	+7.58%	—	$10,758
1Y	+89.69%	89.69%	+89.69%	—	$18,969
3Y	+574.26%	88.92%	+574.26%	—	$67,426
5Y	+135.64%	18.70%	+135.64%	—	$23,564
10Y	-54.30%	-7.53%	-54.30%	—	$4,570
15Y	-50.29%	-4.55%	-50.29%	—	$4,971
20Y	+186.73%	5.41%	+186.73%	—	$28,673
30Y	+186.74%	3.57%	+186.74%	—	$28,674

Risk & Highlights

Best Year+187.68%2023

Worst Year-68.65%2016

Max Drawdown-21.50%2026-02-17 → 2026-03-13

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+9.08%	+9.08%	—	+0.41%	+8.7pp
2025	+62.37%	+62.37%	—	+16.64%	+45.7pp
2024	+32.44%	+32.44%	—	+24.00%	+8.4pp
2023	+187.68%	+187.68%	—	+24.81%	+162.9pp
2022	-58.97%	-58.97%	—	-19.95%	-39.0pp

AMRX outperformed the S&P 500 by 58.37pp over the past year (+89.69% vs +31.32%).

Loading summary...

AMRX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
AMRXAmneal Pharmaceuticals, Inc.	$4.3B	+10.3%	+7.6%	+89.7%	—	+574.3%	+135.6%	-54.3%
TEVATeva Pharmaceutical Industries Limited	$42.3B	+21.8%	+17.4%	+125.4%	—	+301.0%	+253.1%	-24.0%
VTRSViatris Inc.	$18.4B	+18.9%	+29.0%	+93.8%	+5.7pp	+77.1%	+31.5%	-53.8%
PRGOPerrigo Company plc	$1.7B	+15.8%	-9.6%	-45.6%	+4.7pp	-56.6%	-58.6%	-76.8%
PAHCPhibro Animal Health Corporation	$2.4B	+6.7%	+57.5%	+210.5%	+2.5pp	+318.1%	+136.4%	+207.3%
SLDBSolid Biosciences Inc.	$561M	-7.0%	+32.1%	+113.6%	—	+33.1%	-89.6%	-97.9%
MCKMcKesson Corporation	$91.1B	-13.2%	-9.6%	+5.0%	+0.4pp	+104.0%	+308.4%	+351.9%
CAHCardinal Health, Inc.	$45.1B	-9.9%	-6.4%	+27.6%	+1.3pp	+134.8%	+256.4%	+174.5%
CVSCVS Health Corporation	$111.3B	+18.5%	+10.1%	+35.2%	+4.0pp	+35.9%	+18.4%	+3.9%
PFEPfizer Inc.	$150.8B	-4.8%	+7.0%	+23.4%	+7.5pp	-18.4%	-11.3%	+30.7%
MRKMerck & Co., Inc.	$280.5B	-6.1%	+7.5%	+47.9%	+4.2pp	+3.9%	+73.3%	+171.4%

Compare:AMRX vs TEVA AMRX vs VTRS AMRX vs PRGO AMRX vs TEVA vs VTRS

About AMRX Dividend Returns

Amneal Pharmaceuticals, Inc. (AMRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of AMRX over the past year?

Amneal Pharmaceuticals, Inc. (AMRX) delivered a return of 89.69% over the past year. Since AMRX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in AMRX be worth today?

A $10,000 investment in Amneal Pharmaceuticals, Inc. one year ago would be worth $18,969 today, representing a gain of $8,969.

Q3Does AMRX pay dividends?

Amneal Pharmaceuticals, Inc. (AMRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For AMRX, the total return equals the price-only return.

Q4Did AMRX beat the S&P 500?

Yes, Amneal Pharmaceuticals, Inc. (AMRX) outperformed the S&P 500 by 58.37 percentage points over the past year. AMRX delivered a total return of 89.69%, compared to the S&P 500's 31.32%. This 58.37pp alpha means investors in AMRX earned more than a passive S&P 500 index fund.

Q5What is AMRX's worst drawdown?

Amneal Pharmaceuticals, Inc. (AMRX) experienced a maximum drawdown of -21.50% over the past year, declining from its peak on 2026-02-17 to its trough on 2026-03-13. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is AMRX's long-term total return over 10, 20, or 30 years?

Here are Amneal Pharmaceuticals, Inc. (AMRX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -54.3% (-7.5% CAGR) — $10,000 would have grown to $4,570. Over 20 years: 186.7% total return (5.4% CAGR) — $10,000 → $28,673. Over 30 years: 186.7% total return (3.6% CAGR) — $10,000 → $28,674. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was AMRX's best and worst year?

Amneal Pharmaceuticals, Inc.'s best calendar year was 2023 with a total return of 187.7%. Its worst year was 2016 with a total return of -68.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 256.3 percentage points.